[Study on the detection method for determining the bioactivity of recombinant human interleukin-22].
To develop a method for determining the bioactivity of recombinant human IL-22. pSTAT3-TA-Luc and pcDNA3. 1 plasmids were co-transfect to HepG2 cells to generate stable HepG2/ STAT3 cell line with G418 screen. After treating cell with IL-22, the luciferase activity was assayed. Orthogonal test was used to optimize the assay condition, and then the reproducibility and specificity of the assay was checked. The best condition for this assay are: cell density as 4 x 10(5)/mL, stimulating time as 4 hours, luciferase substrate as 50 microL. 50% effective dose (ED50) of IL-22 assayed by this method is 16.89 ng/mL, relative standard deviation (RSD) is 7.09%. Neutralizing antibody test shows the high specificity. Comparing with ELISA, the method described here has more advantages, including higher stability, easier performance and less cost. Luciferase reporter gene assay method is a fast, sensitive, reproducible method for IL-22 bioactivity determination.